Paysign found using ticker (PAYS) have now 4 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The target price ranges between 9 and 3.3 and has a mean target at 6.33. Now with the previous closing price of 5.03 this indicates there is a potential upside of 25.8%. The 50 day MA is 5.11 and the 200 day MA is 6.8. The market cap for the company is $245m. Visit the company website at: http://www.paysign.com
The potential market cap would be $308m based on the market concensus.
PaySign provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. The company offers various services, including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a proprietary platform. It also develops prepaid card solutions for corporate incentive rewards and corporate expense, per diem and travel payments, healthcare reimbursement payments, pharmaceutical co-pay assistance, donor compensation, and clinical trials; and payroll or general purpose reloadable cards, as well as gift or incentive cards. In addition, the company offers Buy and Bill programs for patients to purchase directly from physician’s office or through an infusion center for physician administered therapies; payment solution for source plasma collection centers; and PaySign Premier, a demand deposit account debit card, as well as customer service center and PaySign Communications Suite services. Its principal target markets for processing services comprise prepaid card issuers, retail and private-label issuers, small third-party processors, and small and mid-size financial institutions in the United States and internationally. The company was formerly known as 3PEA International and changed its name to PaySign in April 2019. PaySign is based in Henderson, Nevada.
